UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

European radiology, 2021-11, Vol.31 (11), p.8692-8702

2021

Volltextzugriff (PDF)

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

The lancet oncology, 2010-08, Vol.11 (8), p.725-732

2010

Volltextzugriff (PDF)

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

World journal of urology, 2021-09, Vol.39 (9), p.3239-3249

2021

Volltextzugriff (PDF)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BMC medicine, 2008-07, Vol.6 (1), p.19-19, Article 19

2008

Volltextzugriff (PDF)

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Volltextzugriff (PDF)

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

BMC urology, 2019-05, Vol.19 (1), p.35-35, Article 35

2019

Volltextzugriff (PDF)

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Volltextzugriff (PDF)

Overdetection in screening for prostate cancer

Current opinion in urology, 2014-05, Vol.24 (3), p.256-263

2014

Volltextzugriff (PDF)

Outcome Following Active Surveillance of Men with Screen-detected Prostate Cancer. Results from the Göteborg Randomised Population-based Prostate Cancer Screening Trial

European urology, 2013-01, Vol.63 (1), p.101-107

2013

Volltextzugriff (PDF)

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

European urology, 2015-04, Vol.67 (4), p.627-636

2015

Volltextzugriff (PDF)

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022-08, Vol.208 (2), p.292-300

2022

Volltextzugriff (PDF)

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Journal of magnetic resonance imaging, 2022-03, Vol.55 (3), p.842-853

2022

Volltextzugriff (PDF)

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

European urology, 2024-03, Vol.85 (3), p.207-214

2024

Volltextzugriff (PDF)

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

Cancer epidemiology, biomarkers & prevention, 2009-07, Vol.18 (7), p.2000-2005

2009

Volltextzugriff (PDF)

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Scandinavian journal of urology, 2021-03, Vol.55 (2), p.116-124

2021

Volltextzugriff (PDF)

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

European urology, 2016-11, Vol.70 (5), p.769-770

2016

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2581-2584

2012

Volltextzugriff (PDF)

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

European urology, 2023-02, Vol.83 (2), p.103-109

2023

Volltextzugriff (PDF)

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

European urology, 2012-11, Vol.62 (5), p.745-752

2012

Volltextzugriff (PDF)

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Annals of internal medicine, 2017-10, Vol.167 (7), p.449

2017

Volltextzugriff (PDF)

Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance

The Journal of urology, 2018-10, Vol.200 (4), p.779-785

2018

Volltextzugriff (PDF)

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

European urology, 2018-04, Vol.73 (4), p.618-627

2018

Volltextzugriff (PDF)

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

Scandinavian journal of urology, 2019-10, Vol.53 (5), p.304-311

2019

Volltextzugriff (PDF)

The drama of prostate cancer diagnostics

The lancet oncology, 2017-03, Vol.18 (3), p.e132-e132

2017

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(174)

Sprache

Englisch
(170)
Schwedisch
(5)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Overdetection in screening for prostate cancer

Outcome Following Active Surveillance of Men with Screen-detected Prostate Cancer. Results from the Göteborg Randomised Population-based Prostate Cancer Screening Trial

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

The drama of prostate cancer diagnostics

Aktive Filter

Suchergebnisse filtern